Track topics on Twitter Track topics that are important to you
Lumendi Ltd., a privately held innovative medical device company, announced today that Chief Executive Officer Peter Johann, Ph.D., is scheduled to present at the Digital Medicine...
Lumendi has completed enrollment of a first-in-human trial of its DiLumen EIP technology, meeting the study’s primary endpoint.
Primary Study Endpoint Reached with no Serious Adverse Events Connecticut-based medical device innovator Lumendi, LLC (www.lumendi.com) reports that it has successfully comple...
The first human trial of the FDA-approved DiLumen Endolumenal Interventional Platform, a single-use sleeve intended for stabi -More-
We have published hundreds of Lumendi Ltd. news stories on BioPortfolio along with dozens of Lumendi Ltd. Clinical Trials and PubMed Articles about Lumendi Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lumendi Ltd. Companies in our database. You can also find out about relevant Lumendi Ltd. Drugs and Medications on this site too.